RhBMP-4 Proactivated Porous Ceramic in Posterior Spinal Fusion

X Guo MD',
Jack CY Cheng MD',
LP Law',
KM Lee PhD',
XD Zhang PhD2,
Arthur FT Mak PhD',
Randy Rosier MD3
'Hong Kong;
2Sichuan, China;
3New York, USA
INTRODUCTION:
Dramatically increased expression of rhBMP4 has been demonstrated
by immunohistochemistry during fracture healing. This suggests
that rhBMP4 may be one of the important regulators of cell
differentiation during bone repair. Application of rhBMP4
in spinal fusion has not been reported. Porous hydroxyapatite
tricalcium phosphate (HATCP) ceramic has been shown to
possess osteoconductive properties in filling bone defects. Aim
of the present study was to study the efficacy of a rhBMP4
proactivated porous HATCP and to compare the results with
the well established allograft model in PSF.
METHODS:
Posterolateral lumbar intertransverse process fusion was performed
on three groups of 18 New Zealand white rabbits with grafts of
size measuring 30x8x6 mm. Group I acted as negative control group
with HATCP blocks alone, and group II as positive control
group with allogenous corticocancellous bone from iliac crest
as implant material. In group III, the experiment group, HATCP
blocks were augmented with 2500 ng rhBMP4 (1.7 ng rhBMP4
per mm3 HATCP) before the implantation. The fusion masses
were evaluated 7 weeks postoperatively. Analysis were done on
undecalcified sections allowing evaluation with microradiography,
fluorescence microscopy and light microscopy.
RESULTS:
Fluorescence microscopy showed the initiation of new bone formation
was earlier in the experiment group than in both control groups.
Microradiography and light microscopy demonstrated that, at 7
weeks postoperatively, the volume of the fusion mass in the experiment
group was statistically significantly larger than that in the
control group. Ossification of cartilage tissue between the transverse
processes in the fusion area was not completed in both control
groups, while uninterrupted bony fusion were observed in all
6 animals in rhBMP4 group.
DISCUSSION:
The results of the present study suggested that, BMP4 proactivated
HATCP has significantly enhanced bony fusion both qualitatively
and quantitatively in PSF than HATCP or allograft alone.